In 2021, the research team at the National Eczema Association (NEA) conducted an online survey to learn about patient/caregiver experiences obtaining prescription treatments for their/their child’s atopic dermatitis and the impact of these experiences on their life.
The information provided in this survey will help guide NEA’s advocacy program to establish and advance policy agendas that address patients’ unmet needs and improve patients’ ability to get quality care and treatment.
Based on the survey responses, the NEA research team found that eczema patients frequently experience issues obtaining the therapies prescribed by their doctors. In addition, insurance coverage issues for atopic dermatitis treatments can be exacerbated by treatment issues for comorbid conditions.